HRMY — HARMONY BIOSCIENCES HLDGS IN
As of Q2 2026, 39 SEC-registered investment managers reported holding HRMY (HARMONY BIOSCIENCES HLDGS IN) in their latest 13F filings, with a combined reported value of $859.39M across 23.67M shares. That is -2.0% by share count (-470.94K shares) versus the previous quarter, while reported value moved +27.3%. Ownership is concentrated: the five largest holders account for 62.0% of reported value and the top ten for 77.9%.
Compared with the prior quarter, 2 opened new positions, 22 added to existing stakes, 14 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
HRMY is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 7.10M | $258.58M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 4.81M | $180.12M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.57M | $130.13M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 1.44M | $52.53M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 1.31M | $47.79M | 0.02% | Reduce |
| Renaissance Technologies history | Q2 2026 | 1.20M | $43.52M | 0.06% | Add |
| Two Sigma Investments history | Q2 2026 | 959.14K | $34.92M | 0.03% | Add |
| AQR Capital Management history | Q2 2026 | 934.33K | $34.02M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 733.68K | $26.71M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 602.99K | $21.95M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 528.52K | $19.24M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 514.09K | $18.25M | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 471.22K | $17.16M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 423.82K | $15.43M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 403.53K | $14.69M | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 362.46K | $13.20M | 0.11% | Add |
| Millennium Management history | Q2 2026 | 319.81K | $11.64M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 319.81K | $11.64M | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 278.85K | $10.15M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 272.93K | $9.94M | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 514.09K sh · $18.25M
- Wellington Management Group 16.31K sh · $593.85K
Fully Exited (vs previous quarter)
- Balyasny Asset Management sold 64.60K sh · $1.81M
- Janus Henderson Group sold 16.40K sh · $459.42K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 5.66M | 6.97M | 6.51M | 6.74M | 6.93M | 7.09M | 7.07M | 7.10M |
| Fidelity Management & Research (FMR) | 4.13M | 4.21M | 4.90M | 5.43M | 5.62M | 5.58M | 5.59M | 5.47M | 5.45M | 5.28M | 5.26M | 5.24M | 5.23M | 5.33M | 5.34M | 4.69M | 3.85M | 3.11M | 3.16M | 3.57M |
| Geode Capital Management | 411.11K | 424.83K | 441.61K | 468.82K | 530.28K | 550.24K | 573.62K | 661.31K | 719.38K | 738.90K | 753.78K | 748.70K | 735.42K | 902.93K | 965.75K | 1.05M | 1.26M | 1.27M | 1.32M | 1.44M |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | — | — | — | 317.57K | 296.62K | 398.41K | 906.91K | 1.30M | 1.49M | 1.38M | 1.31M |
| Renaissance Technologies | 39.40K | 134.80K | 142.50K | 291.80K | 325.00K | 342.70K | 465.80K | 410.40K | 292.10K | 258.50K | 380.10K | 595.80K | 492.60K | 568.67K | 840.37K | 929.47K | 1.14M | 1.07M | 1.08M | 1.20M |
| Two Sigma Investments | — | 11.51K | 228.00K | 35.00K | 136.84K | 183.35K | 228.92K | 358.09K | 124.84K | 10.00K | 70.48K | 93.36K | 143.00K | 275.59K | 345.81K | 238.89K | 225.29K | 206.95K | 733.44K | 959.14K |
| AQR Capital Management | — | — | — | 10.72K | 33.38K | 31.92K | 53.55K | 146.39K | 168.52K | 179.75K | 153.23K | 154.34K | 142.59K | 158.86K | 166.34K | 152.03K | 355.57K | 813.89K | 716.25K | 934.33K |
| Morgan Stanley | 44.48K | 171.11K | 161.57K | 213.48K | 322.78K | 396.32K | 562.07K | 730.02K | 755.45K | 1.09M | 885.35K | 836.11K | 850.68K | 806.88K | 656.10K | 758.86K | 847.89K | 817.51K | 1.03M | 733.68K |
| UBS Group AG | 18.14K | 23.11K | 10.83K | 1.36K | 366 | 8.77K | 19.99K | 59.50K | 15.32K | 44.29K | 113.48K | 55.30K | 95.89K | 235.27K | 182.53K | 160.58K | 503.08K | 297.23K | 447.99K | 602.99K |
| Invesco Ltd | 9.46K | 110.36K | 202.31K | 260.06K | 1.17M | 1.68M | 954.33K | 147.43K | 126.44K | 114.18K | 133.91K | 150.93K | 164.02K | 449.18K | 443.69K | 400.95K | 403.29K | 450.81K | 628.25K | 528.52K |
| JPMorgan Chase & Co | 9.52K | 22.33K | 25.34K | 96.96K | 116.28K | 92.81K | 19.58K | 103.11K | 78.87K | 122.90K | 5.60K | 136.81K | 230.43K | 235.88K | 484.80K | 193.85K | 174.01K | 199.36K | — | 514.09K |
| Northern Trust Corp | 212.31K | 240.82K | 233.13K | 254.53K | 269.02K | 274.85K | 274.27K | 332.28K | 344.31K | 331.52K | 323.51K | 307.27K | 294.12K | 404.46K | 403.54K | 433.94K | 432.76K | 418.94K | 423.23K | 471.22K |
| Charles Schwab Investment Management | 232.03K | 267.05K | 260.39K | 235.32K | 255.71K | 225.69K | 223.91K | 248.18K | 290.91K | 319.17K | 373.52K | 374.71K | 371.44K | 472.03K | 466.07K | 437.84K | 456.40K | 417.95K | 411.60K | 423.82K |
| Goldman Sachs Group | 54.52K | 46.91K | 63.66K | 68.28K | 165.61K | 109.02K | 328.33K | 317.00K | 201.96K | 271.10K | 210.95K | 455.36K | 308.01K | 495.05K | 344.77K | 720.68K | 646.65K | 569.36K | 1.24M | 403.53K |
| Royce & Associates | 229.39K | 219.08K | 255.81K | 268.20K | 296.01K | 230.27K | 332.33K | 219.58K | 280.35K | 109.60K | 98.24K | 90.12K | 78.70K | 81.76K | 81.76K | 81.50K | 81.76K | 278.19K | 356.67K | 362.46K |
| Millennium Management | 53.66K | 10.33K | 14.68K | — | 27.95K | 186.93K | 483.03K | 549.50K | 156.50K | 22.43K | 202.73K | 307.42K | 70.81K | 6.33K | 85.49K | 29.29K | 204.51K | 246.70K | 954.36K | 319.81K |
| Citadel Advisors | 41.05K | 90.43K | 168.48K | 107.06K | 229.80K | 142.35K | 576.21K | 843.96K | 288.28K | 120.23K | 607.22K | 703.22K | 173.18K | 1.40M | 879.41K | 35.20K | 192.31K | 508.31K | 677.62K | 319.81K |
| MFS Investment Management | 667.78K | 559.87K | — | 386.91K | 415.45K | 340.10K | 410.94K | 507.33K | 508.20K | 508.63K | 506.15K | 519.70K | 660.39K | 829.62K | 753.55K | 644.53K | 570.54K | 541.28K | 270.01K | 278.85K |
| BNY Mellon | 68.55K | 199.41K | 217.30K | 227.12K | 269.40K | 273.64K | 260.57K | 253.86K | 264.39K | 303.49K | 288.65K | 269.83K | 233.37K | 265.64K | 262.24K | 271.44K | 264.69K | 264.42K | 264.41K | 272.93K |
| Principal Global Investors | — | 158.56K | 195.74K | 190.83K | 197.98K | 192.35K | 186.66K | 183.49K | 199.75K | 198.04K | 192.05K | 182.12K | 162.47K | 208.66K | 213.42K | 230.61K | 230.93K | 252.57K | 258.68K | 265.24K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details